HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
119478.0,231668,2122-12-25 06:44:00,Physician ,Physician Resident Progress Note,"TITLE:
   24 Hour Events:
   - lasix gtt @ 10mg/hour
   - milrinone gtt @ 0.5mcg/kg/min
   - net -2L per 24 hours
   Allergies:
   Amiodarone
   Hyperthyroidism
   Last dose of Antibiotics:
   Infusions:
   Milrinone - 0.1 mcg/Kg/min
   Furosemide (Lasix) - 6 mg/hour
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2122-12-25**] 12:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2122-12-25**] 06:42 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.8
   Tcurrent: 37
C (98.6
   HR: 80 (78 - 103) bpm
   BP: 86/41(51) {71/27(38) - 106/53(78)} mmHg
   RR: 28 (13 - 31) insp/min
   SpO2: 94%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 91.3 kg (admission): 93.8 kg
             Total In:
                                                                  2,054 mL
                                                                    113 mL
   PO:
                                                                  1,410 mL
                                                                     30 mL
   TF:
   IVF:
                                                                    644 mL
                                                                     83 mL
   Blood products:
   Total out:
                                                                  4,240 mL
                                                                    970 mL
   Urine:
                                                                  4,240 mL
                                                                    970 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -2,186 mL
                                                                   -857 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 94%
   ABG: ///26/
   Physical Examination
   Gen: Lying flat, comfortable, NAD. Oriented x3. Mood, affect
   appropriate. Portugese speaking.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   Neck: supple. JVP 6mm
   CV: Irregularly irregular, I/VI HSM LLSB,
   Chest: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. CTAB, no crackles, wheezes or
   rhonchi.
   Abd: Soft, NTND, obese. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   Ext: Trace LE edema b/l, warm.
   Skin: b/l venous stasis changes
   Labs / Radiology
   165 K/uL
   12.3 g/dL
   87 mg/dL
   1.6 mg/dL
   26 mEq/L
   4.5 mEq/L
   40 mg/dL
   97 mEq/L
   135 mEq/L
   35.4 %
   11.6 K/uL
         [image002.jpg]
                             [**2122-12-23**]  06:06 AM
                             [**2122-12-23**]  04:59 PM
                             [**2122-12-24**]  03:56 AM
                             [**2122-12-24**]  02:48 PM
                             [**2122-12-25**]  04:07 AM
   WBC
   9.5
   9.8
   11.6
   Hct
   31.3
   32.4
   31.5
   35.4
   Plt
   148
   145
   165
   Cr
   1.5
   1.6
   1.5
   1.6
   1.6
   Glucose
   97
   130
   101
   87
   Other labs: PT / PTT / INR:22.6/38.9/2.2, Ca++:8.8 mg/dL, Mg++:2.5
   mg/dL, PO4:4.5 mg/dL
   Assessment and Plan
 HEART FAILURE (CHF), SYSTOLIC, ACUTE ON CHRONIC
   Patient is a 32M with idiopathic dilated CM (EF 20%), afib, CVA, SDH,
   and hypothyroidism who is admitted for diuresis and milrinone.
   .
   # PUMP: CHF/Dilated Cardiomyopathy: TTE [**8-3**] showed EF 20%, diagnosed
   after presenting with Class III CHF symptoms in [**9-27**], thought to be
   viral etiology, s/p AICD. His dry weight is 100 kg, currently below dry
   weight at 93kg. Had recent admission at OSH where he presented with LE
   swelling and received IV lasix.  Currently does not appear volume
   overloaded, JVP flat, lungs clear and only trace edema. Plan as
   outlined by Dr. [**First Name (STitle) **]:
   - continue metoprolol 200mg tid to suppress arrythmogenic effects of
   milrinone
   - continue milrinone infusion at .5 mcg/kg/min, can titrate up to
   0.75mcg/kg/min.
   - Start to wean off milrinone late tonight
   - Maintain SBP>80, MAP>40
   - continue digoxin
   - continue lasix gtt, titrate to net negative ~1L daily, inc. to 10
   today
   - continue fluid restriction
   - continue low-dose ACEI
   .
   # RHYTHM: Chronic atrial fibrillation, on Coumadin, diagnosed in the
   setting of hyperthyroidism. Coumadin held [**Date range (1) 2788**] s/p SDH.
   Initially held this hospitalization for INR 3.5.  INR today 2.9
   - restart lower dose coumadin
   - uptitrate metoprolol as above
   .
   # h/o Ventricular Tachycardia: first noted in [**9-27**], had non sustained
   30 second run seen on Holter [**8-29**], s/p syncope from VT in [**9-1**].
   - monitor on telemetry
   - ICD in place
   - maintain K >4, Mg >2
   .
   # NEURO: s/p CVA as well as SDH. On Keppra for sz prophylaxis.
   Admitted to OSH in [**9-2**] after seizure at home and he was started on
   Keppra. Has been seizure free.
   - Cont Keppra 250mg [**Hospital1 **]
   .
   # Thyroid dysfunction: Originally had hyperthyroidism, secondary to
   Amiodarone (d/ced [**3-1**]), s/p prednisone and methimazole-->
   hypothyroidism
   -continue synthroid
   .
   # CRI: Baseline Cr 1.7-1.8.  Likely related to poor forward flow. Cr
   down to below baseline today at 1.5 with diuresis.
   - Cont to follow with diuresis
   - renally dose meds
   .
   # Anemia: Baseline Hct in low 30s.  Iron studies c/w chronic disease.
   Currently at baseline, no signs of bleeding
   -Cont. to follow
   -GAS
   .
   # Osteoporosis: continue Ca, Vitamin D
   .
   # FEN: low Na diet, follow and replete lytes, fluid restrict 1.5L
   .
   # Access: PIV x2, ? PICC for home milrinone
   .
   # PPx: therapeutic on coumadin
   .
   # Code: FULL
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   22 Gauge - [**2122-12-24**] 06:18 AM
   18 Gauge - [**2122-12-24**] 04:26 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
   `
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   24 Hour Events:
   - lasix gtt @ 10mg/hour
   - milrinone gtt @ 0.5mcg/kg/min
   - net -2L per 24 hours
   Allergies:
   Amiodarone
   Hyperthyroidism
   Last dose of Antibiotics:
   Infusions:
   Milrinone - 0.1 mcg/Kg/min
   Furosemide (Lasix) - 6 mg/hour
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2122-12-25**] 12:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2122-12-25**] 06:42 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.8
   Tcurrent: 37
C (98.6
   HR: 80 (78 - 103) bpm
   BP: 86/41(51) {71/27(38) - 106/53(78)} mmHg
   RR: 28 (13 - 31) insp/min
   SpO2: 94%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 91.3 kg (admission): 93.8 kg
             Total In:
                                                                  2,054 mL
                                                                    113 mL
   PO:
                                                                  1,410 mL
                                                                     30 mL
   TF:
   IVF:
                                                                    644 mL
                                                                     83 mL
   Blood products:
   Total out:
                                                                  4,240 mL
                                                                    970 mL
   Urine:
                                                                  4,240 mL
                                                                    970 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -2,186 mL
                                                                   -857 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 94%
   ABG: ///26/
   Physical Examination
   Gen: Lying flat, comfortable, NAD. Oriented x3. Mood, affect
   appropriate. Portugese speaking.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   Neck: supple. JVP 6mm
   CV: Irregularly irregular, I/VI HSM LLSB,
   Chest: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. CTAB, no crackles, wheezes or
   rhonchi.
   Abd: Soft, NTND, obese. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   Ext: Trace LE edema b/l, warm.
   Skin: b/l venous stasis changes
   Labs / Radiology
   165 K/uL
   12.3 g/dL
   87 mg/dL
   1.6 mg/dL
   26 mEq/L
   4.5 mEq/L
   40 mg/dL
   97 mEq/L
   135 mEq/L
   35.4 %
   11.6 K/uL
         [image002.jpg]
                             [**2122-12-23**]  06:06 AM
                             [**2122-12-23**]  04:59 PM
                             [**2122-12-24**]  03:56 AM
                             [**2122-12-24**]  02:48 PM
                             [**2122-12-25**]  04:07 AM
   WBC
   9.5
   9.8
   11.6
   Hct
   31.3
   32.4
   31.5
   35.4
   Plt
   148
   145
   165
   Cr
   1.5
   1.6
   1.5
   1.6
   1.6
   Glucose
   97
   130
   101
   87
   Other labs: PT / PTT / INR:22.6/38.9/2.2, Ca++:8.8 mg/dL, Mg++:2.5
   mg/dL, PO4:4.5 mg/dL
   Assessment and Plan
 HEART FAILURE (CHF), SYSTOLIC, ACUTE ON CHRONIC
   Patient is a 32M with idiopathic dilated CM (EF 20%), afib, CVA, SDH,
   and hypothyroidism who is admitted for diuresis and milrinone.
   .
   # PUMP: CHF/Dilated Cardiomyopathy: TTE [**8-3**] showed EF 20%, diagnosed
   after presenting with Class III CHF symptoms in [**9-27**], thought to be
   viral etiology, s/p AICD. His dry weight is 100 kg, currently below dry
   weight at 93kg. Had recent admission at OSH where he presented with LE
   swelling and received IV lasix.  Currently does not appear volume
   overloaded, JVP flat, lungs clear and only trace edema. Plan as
   outlined by Dr. [**First Name (STitle) **]:
   - continue metoprolol 200mg tid to suppress arrythmogenic effects of
   milrinone
   - continue milrinone infusion at .5 mcg/kg/min, can titrate up to
   0.75mcg/kg/min.
   - Start to wean off milrinone late tonight
   - Maintain SBP>80, MAP>40
   - continue digoxin
   - continue lasix gtt, titrate to net negative ~1L daily, inc. to 10
   today
   - continue fluid restriction
   - continue low-dose ACEI
   .
   # RHYTHM: Chronic atrial fibrillation, on Coumadin, diagnosed in the
   setting of hyperthyroidism. Coumadin held [**Date range (1) 2788**] s/p SDH.
   Initially held this hospitalization for INR 3.5.  INR today 2.9
   - restart lower dose coumadin
   - uptitrate metoprolol as above
   .
   # h/o Ventricular Tachycardia: first noted in [**9-27**], had non sustained
   30 second run seen on Holter [**8-29**], s/p syncope from VT in [**9-1**].
   - monitor on telemetry
   - ICD in place
   - maintain K >4, Mg >2
   .
   # NEURO: s/p CVA as well as SDH. On Keppra for sz prophylaxis.
   Admitted to OSH in [**9-2**] after seizure at home and he was started on
   Keppra. Has been seizure free.
   - Cont Keppra 250mg [**Hospital1 **]
   .
   # Thyroid dysfunction: Originally had hyperthyroidism, secondary to
   Amiodarone (d/ced [**3-1**]), s/p prednisone and methimazole-->
   hypothyroidism
   -continue synthroid
   .
   # CRI: Baseline Cr 1.7-1.8.  Likely related to poor forward flow. Cr
   down to below baseline today at 1.5 with diuresis.
   - Cont to follow with diuresis
   - renally dose meds
   .
   # Anemia: Baseline Hct in low 30s.  Iron studies c/w chronic disease.
   Currently at baseline, no signs of bleeding
   -Cont. to follow
   -GAS
   .
   # Osteoporosis: continue Ca, Vitamin D
   .
   # FEN: low Na diet, follow and replete lytes, fluid restrict 1.5L
   .
   # Access: PIV x2, ? PICC for home milrinone
   .
   # PPx: therapeutic on coumadin
   .
   # Code: FULL
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   22 Gauge - [**2122-12-24**] 06:18 AM
   18 Gauge - [**2122-12-24**] 04:26 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
   `<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's 24-hour progress note, the following summary can be made:

The patient is a 32-year-old male admitted to the ICU for diuresis and milrinone treatment due to acute on chronic heart failure (CHF) with systolic dysfunction, atrial fibrillation (AF), and a history of stroke and hypothyroidism. The patient has a dry weight of 100 kg and is currently below dry weight at 93 kg. He has been receiving milrinone infusion at 0.5 mcg/kg/min and furosemide (Lasix) at 6 mg/hour.

The patient's vital signs are stable, with a temperature of 37.1°C, heart rate of 80 bpm, blood pressure of 86/41 mmHg, and oxygen saturation of 94%. He has a regular atrial fibrillation rhythm and is receiving digoxin. His laboratory results show a white blood cell count of 9.5 x 10^9/L, hemoglobin of 12.3 g/dL, platelet count of 148 x 10^9/L, and creatinine of 1.5 mg/dL.

The patient's physical examination shows no significant changes, with a supple neck, no jugular venous distension, and no chest wall deformities. His abdomen is soft and non-tender, and he has trace lower extremity edema.

The patient's medical history includes idiopathic dilated cardiomyopathy, atrial fibrillation, stroke, and hypothyroidism. He has a history of ventricular tachycardia and is receiving an implantable cardioverter-defibrillator (ICD). He has also had a subdural hematoma and is receiving Keppra for seizure prophylaxis.

Potential medical complications that can arise from the patient's conditions include:

1. Worsening heart failure: The patient's heart failure is acute on chronic, and there is a risk of worsening heart failure if the patient's diuresis is not adequate.
2. Atrial fibrillation: The patient's atrial fibrillation is chronic, and there is a risk of worsening atrial fibrillation if the patient's heart failure worsens.
3. Stroke: The patient has a history of stroke and is at risk of having another stroke if his atrial fibrillation worsens.
4. Hypothyroidism: The patient has hypothyroidism and is at risk of developing thyroid storm if his thyroid function is not properly managed.
5. Anemia: The patient has anemia, and there is a risk of worsening anemia if his heart failure worsens.
6. Osteoporosis: The patient has osteoporosis, and there is a risk of developing osteoporosis-related fractures if his bone density is not properly managed.
7. Electrolyte imbalance: The patient has a history of electrolyte imbalance, and there is a risk of developing electrolyte imbalance if his diuresis is not adequate.
8. Infection: The patient is at risk of developing infection if his immune system is compromised.

Overall, the patient requires close monitoring and management to prevent and treat these potential complications."
119478.0,231668,2122-12-25 06:44:00,Physician ,Physician Resident Progress Note,"TITLE:
   24 Hour Events:
   - lasix gtt @ 10mg/hour
   - milrinone gtt @ 0.5mcg/kg/min
   - net -2L per 24 hours
   Allergies:
   Amiodarone
   Hyperthyroidism
   Last dose of Antibiotics:
   Infusions:
   Milrinone - 0.1 mcg/Kg/min
   Furosemide (Lasix) - 6 mg/hour
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2122-12-25**] 12:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2122-12-25**] 06:42 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.8
   Tcurrent: 37
C (98.6
   HR: 80 (78 - 103) bpm
   BP: 86/41(51) {71/27(38) - 106/53(78)} mmHg
   RR: 28 (13 - 31) insp/min
   SpO2: 94%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 91.3 kg (admission): 93.8 kg
             Total In:
                                                                  2,054 mL
                                                                    113 mL
   PO:
                                                                  1,410 mL
                                                                     30 mL
   TF:
   IVF:
                                                                    644 mL
                                                                     83 mL
   Blood products:
   Total out:
                                                                  4,240 mL
                                                                    970 mL
   Urine:
                                                                  4,240 mL
                                                                    970 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -2,186 mL
                                                                   -857 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 94%
   ABG: ///26/
   Physical Examination
   Gen: Lying flat, comfortable, NAD. Oriented x3. Mood, affect
   appropriate. Portugese speaking.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   Neck: supple. JVP 6mm
   CV: Irregularly irregular, I/VI HSM LLSB,
   Chest: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. CTAB, no crackles, wheezes or
   rhonchi.
   Abd: Soft, NTND, obese. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   Ext: Trace LE edema b/l, warm.
   Skin: b/l venous stasis changes
   Labs / Radiology
   165 K/uL
   12.3 g/dL
   87 mg/dL
   1.6 mg/dL
   26 mEq/L
   4.5 mEq/L
   40 mg/dL
   97 mEq/L
   135 mEq/L
   35.4 %
   11.6 K/uL
        [image002.jpg]
                             [**2122-12-23**]  06:06 AM
                             [**2122-12-23**]  04:59 PM
                             [**2122-12-24**]  03:56 AM
                             [**2122-12-24**]  02:48 PM
                             [**2122-12-25**]  04:07 AM
   WBC
   9.5
   9.8
   11.6
   Hct
   31.3
   32.4
   31.5
   35.4
   Plt
   148
   145
   165
   Cr
   1.5
   1.6
   1.5
   1.6
   1.6
   Glucose
   97
   130
   101
   87
   Other labs: PT / PTT / INR:22.6/38.9/2.2, Ca++:8.8 mg/dL, Mg++:2.5
   mg/dL, PO4:4.5 mg/dL
   Assessment and Plan
 HEART FAILURE (CHF), SYSTOLIC, ACUTE ON CHRONIC
   Patient is a 32M with idiopathic dilated CM (EF 20%), afib, CVA, SDH,
   and hypothyroidism who is admitted for diuresis and milrinone.
   .
   # PUMP: CHF/Dilated Cardiomyopathy: TTE [**8-3**] showed EF 20%, diagnosed
   after presenting with Class III CHF symptoms in [**9-27**], thought to be
   viral etiology, s/p AICD. His dry weight is 100 kg, currently below dry
   weight at 93kg. Had recent admission at OSH where he presented with LE
   swelling and received IV lasix.  Currently does not appear volume
   overloaded, JVP flat, lungs clear and only trace edema. Plan as
   outlined by Dr. [**First Name (STitle) **]:
   - continue metoprolol 200mg tid to suppress arrythmogenic effects of
   milrinone
   - continue milrinone infusion at .5 mcg/kg/min, can titrate up to
   0.75mcg/kg/min.
   - Start to wean off milrinone late tonight
   - Maintain SBP>80, MAP>40
   - continue digoxin
   - continue lasix gtt, titrate to net negative ~1L daily, inc. to 10
   today
   - continue fluid restriction
   - continue low-dose ACEI
   .
   # RHYTHM: Chronic atrial fibrillation, on Coumadin, diagnosed in the
   setting of hyperthyroidism. Coumadin held [**Date range (1) 2788**] s/p SDH.
   Initially held this hospitalization for INR 3.5.  INR today 2.9
   - restart lower dose coumadin
   - uptitrate metoprolol as above
   .
   # h/o Ventricular Tachycardia: first noted in [**9-27**], had non sustained
   30 second run seen on Holter [**8-29**], s/p syncope from VT in [**9-1**].
   - monitor on telemetry
   - ICD in place
   - maintain K >4, Mg >2
   .
   # NEURO: s/p CVA as well as SDH. On Keppra for sz prophylaxis.
   Admitted to OSH in [**9-2**] after seizure at home and he was started on
   Keppra. Has been seizure free.
   - Cont Keppra 250mg [**Hospital1 **]
   .
   # Thyroid dysfunction: Originally had hyperthyroidism, secondary to
   Amiodarone (d/ced [**3-1**]), s/p prednisone and methimazole-->
   hypothyroidism
   -continue synthroid
   .
   # CRI: Baseline Cr 1.7-1.8.  Likely related to poor forward flow. Cr
   down to below baseline today at 1.5 with diuresis.
   - Cont to follow with diuresis
   - renally dose meds
   .
   # Anemia: Baseline Hct in low 30s.  Iron studies c/w chronic disease.
   Currently at baseline, no signs of bleeding
   -Cont. to follow
   -GAS
   .
   # Osteoporosis: continue Ca, Vitamin D
   .
   # FEN: low Na diet, follow and replete lytes, fluid restrict 1.5L
   .
   # Access: PIV x2, ? PICC for home milrinone
   .
   # PPx: therapeutic on coumadin
   .
   # Code: FULL
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   22 Gauge - [**2122-12-24**] 06:18 AM
   18 Gauge - [**2122-12-24**] 04:26 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
   `
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   24 Hour Events:
   - lasix gtt @ 10mg/hour
   - milrinone gtt @ 0.5mcg/kg/min
   - net -2L per 24 hours
   Allergies:
   Amiodarone
   Hyperthyroidism
   Last dose of Antibiotics:
   Infusions:
   Milrinone - 0.1 mcg/Kg/min
   Furosemide (Lasix) - 6 mg/hour
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2122-12-25**] 12:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2122-12-25**] 06:42 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.8
   Tcurrent: 37
C (98.6
   HR: 80 (78 - 103) bpm
   BP: 86/41(51) {71/27(38) - 106/53(78)} mmHg
   RR: 28 (13 - 31) insp/min
   SpO2: 94%
   Heart rhythm: AF (Atrial Fibrillation)
   Wgt (current): 91.3 kg (admission): 93.8 kg
             Total In:
                                                                  2,054 mL
                                                                    113 mL
   PO:
                                                                  1,410 mL
                                                                     30 mL
   TF:
   IVF:
                                                                    644 mL
                                                                     83 mL
   Blood products:
   Total out:
                                                                  4,240 mL
                                                                    970 mL
   Urine:
                                                                  4,240 mL
                                                                    970 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -2,186 mL
                                                                   -857 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 94%
   ABG: ///26/
   Physical Examination
   Gen: Lying flat, comfortable, NAD. Oriented x3. Mood, affect
   appropriate. Portugese speaking.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   Neck: supple. JVP 6mm
   CV: Irregularly irregular, I/VI HSM LLSB,
   Chest: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. CTAB, no crackles, wheezes or
   rhonchi.
   Abd: Soft, NTND, obese. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   Ext: Trace LE edema b/l, warm.
   Skin: b/l venous stasis changes
   Labs / Radiology
   165 K/uL
   12.3 g/dL
   87 mg/dL
   1.6 mg/dL
   26 mEq/L
   4.5 mEq/L
   40 mg/dL
   97 mEq/L
   135 mEq/L
   35.4 %
   11.6 K/uL
        [image002.jpg]
                             [**2122-12-23**]  06:06 AM
                             [**2122-12-23**]  04:59 PM
                             [**2122-12-24**]  03:56 AM
                             [**2122-12-24**]  02:48 PM
                             [**2122-12-25**]  04:07 AM
   WBC
   9.5
   9.8
   11.6
   Hct
   31.3
   32.4
   31.5
   35.4
   Plt
   148
   145
   165
   Cr
   1.5
   1.6
   1.5
   1.6
   1.6
   Glucose
   97
   130
   101
   87
   Other labs: PT / PTT / INR:22.6/38.9/2.2, Ca++:8.8 mg/dL, Mg++:2.5
   mg/dL, PO4:4.5 mg/dL
   Assessment and Plan
 HEART FAILURE (CHF), SYSTOLIC, ACUTE ON CHRONIC
   Patient is a 32M with idiopathic dilated CM (EF 20%), afib, CVA, SDH,
   and hypothyroidism who is admitted for diuresis and milrinone.
   .
   # PUMP: CHF/Dilated Cardiomyopathy: TTE [**8-3**] showed EF 20%, diagnosed
   after presenting with Class III CHF symptoms in [**9-27**], thought to be
   viral etiology, s/p AICD. His dry weight is 100 kg, currently below dry
   weight at 93kg. Had recent admission at OSH where he presented with LE
   swelling and received IV lasix.  Currently does not appear volume
   overloaded, JVP flat, lungs clear and only trace edema. Plan as
   outlined by Dr. [**First Name (STitle) **]:
   - continue metoprolol 200mg tid to suppress arrythmogenic effects of
   milrinone
   - continue milrinone infusion at .5 mcg/kg/min, can titrate up to
   0.75mcg/kg/min.
   - Start to wean off milrinone late tonight
   - Maintain SBP>80, MAP>40
   - continue digoxin
   - continue lasix gtt, titrate to net negative ~1L daily, inc. to 10
   today
   - continue fluid restriction
   - continue low-dose ACEI
   .
   # RHYTHM: Chronic atrial fibrillation, on Coumadin, diagnosed in the
   setting of hyperthyroidism. Coumadin held [**Date range (1) 2788**] s/p SDH.
   Initially held this hospitalization for INR 3.5.  INR today 2.9
   - restart lower dose coumadin
   - uptitrate metoprolol as above
   .
   # h/o Ventricular Tachycardia: first noted in [**9-27**], had non sustained
   30 second run seen on Holter [**8-29**], s/p syncope from VT in [**9-1**].
   - monitor on telemetry
   - ICD in place
   - maintain K >4, Mg >2
   .
   # NEURO: s/p CVA as well as SDH. On Keppra for sz prophylaxis.
   Admitted to OSH in [**9-2**] after seizure at home and he was started on
   Keppra. Has been seizure free.
   - Cont Keppra 250mg [**Hospital1 **]
   .
   # Thyroid dysfunction: Originally had hyperthyroidism, secondary to
   Amiodarone (d/ced [**3-1**]), s/p prednisone and methimazole-->
   hypothyroidism
   -continue synthroid
   .
   # CRI: Baseline Cr 1.7-1.8.  Likely related to poor forward flow. Cr
   down to below baseline today at 1.5 with diuresis.
   - Cont to follow with diuresis
   - renally dose meds
   .
   # Anemia: Baseline Hct in low 30s.  Iron studies c/w chronic disease.
   Currently at baseline, no signs of bleeding
   -Cont. to follow
   -GAS
   .
   # Osteoporosis: continue Ca, Vitamin D
   .
   # FEN: low Na diet, follow and replete lytes, fluid restrict 1.5L
   .
   # Access: PIV x2, ? PICC for home milrinone
   .
   # PPx: therapeutic on coumadin
   .
   # Code: FULL
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   22 Gauge - [**2122-12-24**] 06:18 AM
   18 Gauge - [**2122-12-24**] 04:26 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
   `<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's 24-hour progress note, here is a summary of the information and potential medical complications that can arise:

**Summary:**

The patient is a 32-year-old male with idiopathic dilated cardiomyopathy (EF 20%), atrial fibrillation, CVA, and hypothyroidism. He was admitted for diuresis and milrinone therapy. His current vital signs are stable, with a heart rate of 80 beats per minute, blood pressure of 86/41 mmHg, and oxygen saturation of 94%. He has a history of chronic atrial fibrillation, ventricular tachycardia, and seizure disorder. His lab results show normal renal function, anemia, and electrolyte imbalances.

**Potential Medical Complications:**

1. **Cardiac Complications:**
	* Sudden cardiac death due to ventricular tachycardia or atrial fibrillation.
	* Worsening of heart failure symptoms.
	* Increased risk of arrhythmias with milrinone therapy.
2. **Renal Complications:**
	* Acute kidney injury due to decreased renal perfusion or milrinone-induced nephrotoxicity.
	* Fluid overload or electrolyte imbalances due to diuresis.
3. **Neurological Complications:**
	* Seizure recurrence or worsening of seizure disorder.
	* Increased risk of cerebral edema or hemorrhage due to hypothyroidism.
4. **Thyroid Complications:**
	* Hypothyroidism exacerbation or worsening of symptoms.
	* Potential for thyroid storm if not adequately treated.
5. **Infection Complications:**
	* Ventilator-associated pneumonia (VAP) or other nosocomial infections due to prolonged ICU stay.
	* Increased risk of sepsis or septic shock due to compromised immune function.
6. **Other Complications:**
	* Respiratory failure or acute respiratory distress syndrome (ARDS) due to fluid overload or pulmonary edema.
	* Gastrointestinal bleeding or obstruction due to prolonged ICU stay and medication use.

**Recommendations:**

1. Monitor the patient's cardiac status closely, including heart rate, blood pressure, and oxygen saturation.
2. Adjust milrinone therapy as needed to prevent arrhythmias and worsening of heart failure symptoms.
3. Monitor renal function and electrolyte imbalances, and adjust diuresis and medication therapy accordingly.
4. Continue to monitor the patient's neurological status, including seizure activity and thyroid function.
5. Implement measures to prevent nosocomial infections, such as proper hand hygiene, isolation precautions, and prompt treatment of any suspected infections.
6. Monitor the patient's respiratory status and adjust therapy as needed to prevent respiratory failure or ARDS.
7. Continue to monitor the patient's gastrointestinal status and adjust therapy as needed to prevent bleeding or obstruction."
